We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current TIL market cap is 64.06M. The company's latest EPS is USD -23.9989 and P/E is -0.41.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -58.45M | -20.99M | -50.48M | -12.98M | -23.96M |
| Net Income | -57.07M | -18.66M | -67.43M | -12.93M | -24.3M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 138k | 0 | 0 | 0 |
| Operating Income | -6.59M | -33.64M | -155.56M | -226.46M | -142.9M |
| Net Income | -6.52M | -37.74M | -156.79M | -223.18M | -156.09M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 427.17M | 408.31M | 340.27M | 325.63M | 306.3M |
| Total Liabilities | 116.02M | 111.79M | 106.25M | 99.8M | 100.48M |
| Total Equity | 311.15M | 296.52M | 234.02M | 225.83M | 205.83M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 9.48M | 319.01M | 609.98M | 482.13M | 325.63M |
| Total Liabilities | 1.42M | 26.65M | 54.78M | 118.52M | 99.8M |
| Total Equity | -6.89M | -39.6M | 555.2M | 363.61M | 225.83M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -34.66M | -54.22M | -68.65M | -82.03M | -14.39M |
| Investing | 14.53M | 24.86M | 27.18M | 41.13M | 9.24M |
| Financing | 4.47M | 8.67M | 8.08M | 8.08M | N/A |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.29M | -29.62M | -122.14M | -180.16M | -82.03M |
| Investing | -760k | -51.12M | -474.4M | 114.54M | 41.13M |
| Financing | 14.95M | 313.05M | 393.16M | 71.89M | 8.08M |
| Market Cap | 64.06M |
| Price to Earnings Ratio | -0.41 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.97 |
| Price to Book Ratio | 0.28 |
| Dividend Yield | - |
| Shares Outstanding | 6.5M |
| Average Volume (1 week) | 6.3k |
| Average Volume (1 Month) | 6.38k |
| 52 Week Change | -8.80% |
| 52 Week High | 12.98 |
| 52 Week Low | 6.07 |
| Spread (Intraday) | 2.05 (17.04%) |
| Company Name | Instill Bio Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://instilbio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
